Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer

被引:1512
作者
Ritchie, MD
Hahn, LW
Roodi, N
Bailey, LR
Dupont, WD
Parl, FF
Moore, JH
机构
[1] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Program Human Genet, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA
关键词
D O I
10.1086/321276
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
One of the greatest challenges facing human geneticists is the identification and characterization of susceptibility genes for common complex multifactorial human diseases. This challenge is partly due to the limitations of parametric-statistical methods for detection of gene effects that are dependent solely or partially on interactions with other genes and with environmental exposures. We introduce multifactor-dimensionality reduction (MDR) as a method for reducing the dimensionality of multilocus information, to improve the identification of polymorphism combinations associated with disease risk. The MDR method is nonparametric (i.e., no hypothesis about the value of a statistical parameter is made), is model-free (i.e., it assumes no particular inheritance model), and is directly applicable to case-control and discordant-sib-pair studies. Using simulated case-control data, we demonstrate that MDR has reasonable power to identify interactions among two or more loci in relatively small samples. When it was applied to a sporadic breast cancer case-control data set, in the absence of any statistically significant independent main effects, MDR identified a statistically significant high-order interaction among four polymorphisms from three different estrogen-metabolism genes. To our knowledge, this is the first report of a four-locus interaction associated with a common complex multifactorial disease.
引用
收藏
页码:138 / 147
页数:10
相关论文
共 44 条
  • [1] AMBROSONE CB, 1995, CANCER RES, V55, P3483
  • [2] [Anonymous], [No title captured]
  • [3] Bailey LR, 1998, CANCER RES, V58, P5038
  • [4] Bailey LR, 1998, CANCER RES, V58, P65
  • [5] Bailey LR, 1999, CANCER RES, V59, P1388
  • [6] Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
  • [7] Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
  • [8] Cantu-Paz E., 2000, EFFICIENT ACCURATE P
  • [9] Cascorbi I, 1996, CANCER RES, V56, P4965
  • [10] Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
    Cavalieri, EL
    Stack, DE
    Devanesan, PD
    Todorovic, R
    Dwivedy, I
    Higginbotham, S
    Johansson, SL
    Patil, KD
    Gross, ML
    Gooden, JK
    Ramanathan, R
    Cerny, RL
    Rogan, EG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10937 - 10942